[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

BR9912889A - Carboxylic acid derivative, pharmaceutical preparation, use of carboxylic acid derivatives, use of compounds, preparation of pharmaceutical combination, use of a structural fragment, and, compound - Google Patents

Carboxylic acid derivative, pharmaceutical preparation, use of carboxylic acid derivatives, use of compounds, preparation of pharmaceutical combination, use of a structural fragment, and, compound

Info

Publication number
BR9912889A
BR9912889A BR9912889-6A BR9912889A BR9912889A BR 9912889 A BR9912889 A BR 9912889A BR 9912889 A BR9912889 A BR 9912889A BR 9912889 A BR9912889 A BR 9912889A
Authority
BR
Brazil
Prior art keywords
carboxylic acid
preparation
pharmaceutical
compounds
compound
Prior art date
Application number
BR9912889-6A
Other languages
Portuguese (pt)
Inventor
Wilheim Amberg
Rolf Jansen
Georg Kettschau
Stefan Hergenroeder
Manfred Raschack
Liliane Unger
Original Assignee
Basf Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Basf Ag filed Critical Basf Ag
Publication of BR9912889A publication Critical patent/BR9912889A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/32—One oxygen, sulfur or nitrogen atom
    • C07D239/34—One oxygen atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/08—Drugs for disorders of the urinary system of the prostate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/52—Two oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

"DERIVADO DE áCIDO CARBOXìLICO, PREPARAçãO FARMACêUTICA, USO DOS DERIVADOS DO áCIDO CARBOXìLICO, USO DOS COMPOSTOS, PREPARAçãO DE COMBINAçãO FARMACêUTICA, USO DE UM FRAGMENTO ESTRUTURAL, E, COMPOSTO" A invenção diz respeito a novos derivados de ácido carboxílico da fórmula I onde os substituintes têm os significados explicados na descrição, à sua preparação e ao seu uso como antagonistas do receptor de endotelina."CARBOXYLIC ACID DERIVATIVE, PHARMACEUTICAL PREPARATION, USE OF CARBOXYLIC ACID DERIVATIVES, USE OF COMPOUNDS, PREPARATION OF PHARMACEUTICAL COMBINATION, USE OF A STRUCTURAL FRAGMENT, AND, COMPOUND" the invention relates to new acid derivatives substituents have the meanings explained in the description, their preparation and their use as endothelin receptor antagonists.

BR9912889-6A 1998-08-10 1999-08-07 Carboxylic acid derivative, pharmaceutical preparation, use of carboxylic acid derivatives, use of compounds, preparation of pharmaceutical combination, use of a structural fragment, and, compound BR9912889A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19836044A DE19836044A1 (en) 1998-08-10 1998-08-10 New 2-(hetero)aryl-alkanoic acid derivatives, useful as mixed endothelin receptor antagonists, e.g. for treating cardiac insufficiency, restenosis, hypertension or prostate cancer
PCT/EP1999/005728 WO2000009489A1 (en) 1998-08-10 1999-08-07 New carboxylic acid derivatives carrying keto side-chains, their production and their use as endothelin-receptor antagonists

Publications (1)

Publication Number Publication Date
BR9912889A true BR9912889A (en) 2001-05-08

Family

ID=7876981

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9912889-6A BR9912889A (en) 1998-08-10 1999-08-07 Carboxylic acid derivative, pharmaceutical preparation, use of carboxylic acid derivatives, use of compounds, preparation of pharmaceutical combination, use of a structural fragment, and, compound

Country Status (22)

Country Link
EP (1) EP1104410A1 (en)
JP (1) JP2002522531A (en)
KR (1) KR20010072378A (en)
CN (1) CN1323298A (en)
AR (1) AR020147A1 (en)
AU (1) AU5374199A (en)
BG (1) BG105236A (en)
BR (1) BR9912889A (en)
CA (1) CA2340167A1 (en)
CO (1) CO5261504A1 (en)
DE (1) DE19836044A1 (en)
HK (1) HK1042086A1 (en)
HR (1) HRP20010164A2 (en)
HU (1) HUP0104007A3 (en)
ID (1) ID27965A (en)
IL (1) IL140915A0 (en)
NO (1) NO20010622D0 (en)
PL (1) PL345998A1 (en)
SK (1) SK832001A3 (en)
TR (1) TR200100427T2 (en)
WO (1) WO2000009489A1 (en)
ZA (1) ZA200101975B (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19924892A1 (en) * 1999-06-01 2000-12-07 Basf Ag New carboxylic acid derivatives with aryl-substituted nitrogen heterocycles, their production and use as endothelin receptor antagonists

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19636046A1 (en) * 1996-09-05 1998-03-12 Basf Ag New carboxylic acid derivatives, their production and use as mixed ET¶A¶ / ET¶B¶ receptor antagonists

Also Published As

Publication number Publication date
HUP0104007A2 (en) 2002-05-29
AU5374199A (en) 2000-03-06
HRP20010164A2 (en) 2002-04-30
WO2000009489A1 (en) 2000-02-24
IL140915A0 (en) 2002-02-10
DE19836044A1 (en) 2000-02-17
EP1104410A1 (en) 2001-06-06
ZA200101975B (en) 2002-03-11
BG105236A (en) 2001-12-29
SK832001A3 (en) 2001-11-06
AR020147A1 (en) 2002-04-10
NO20010622L (en) 2001-02-06
KR20010072378A (en) 2001-07-31
HUP0104007A3 (en) 2002-12-28
HK1042086A1 (en) 2002-08-02
TR200100427T2 (en) 2001-07-23
ID27965A (en) 2001-05-03
JP2002522531A (en) 2002-07-23
CA2340167A1 (en) 2000-02-24
CN1323298A (en) 2001-11-21
PL345998A1 (en) 2002-01-14
NO20010622D0 (en) 2001-02-06
CO5261504A1 (en) 2003-03-31

Similar Documents

Publication Publication Date Title
DE59609451D1 (en) SOLID ACTIVE SUBSTANCE PREPARATIONS
BR9916307A (en) Quinoline derivatives
SE8804629D0 (en) NEW THERAPEUTICALLY ACTIVE COMPOUNDS
BR0017030B8 (en) thiazolylamide derivatives, process for their preparation, pharmaceutical composition comprising them and their use
SE9504661D0 (en) New compounds
BR0008840B1 (en) camptothecin derivatives, processes for their preparation, pharmaceutical composition comprising them and use thereof.
PT894084E (en) CINAMIC ACID DERIVATIVES AND THEIR USE AS INTEGRINE ANTAGONISTS
BR9712808A (en) Indol-3-glyoxylamides n-substituted with antiasthmatic, anti-allergic and immunosuppressive / immunomodulatory effect
CY1110988T1 (en) HIGHLY DETERMINED SOLID PREPARATION
FI963566A0 (en) New piperazine derivatives, methods for their preparation and compositions containing them
PT1083171E (en) PYRAZOLINE DERIVATIVES ITS PREPARATION AND APPLICATION AS MEDICINES
NO20011721D0 (en) N-aralkylaminotetralins as ligands for neuropeptide Y Y5 receptor
EE05054B1 (en) Oral pharmaceutical composition of a 5-HT4 agonist or antagonist and its use in medicine
BR9909486A (en) Calcilic compounds
BR9801150A (en) Propanolamine derivatives, processes for preparing them, pharmaceutical products comprising these compounds and their use.
IT9021662A0 (en) PHARMACEUTICAL COMPOSITIONS FOR TOPICAL USE INCLUDING SODIUM HYLUROMICOSAL ACID AND DISINFECTANT SUBSTANCES
MX9300779A (en) 3- (1H-TETRAZOLE-5-Y1) -4H-PYRIDO [1,2-A] PIRIMIDINA-4-ONAS PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM AND THEIR PREPARATION THEREOF
BR9814951A (en) Carboxylic acid derivative, use of it, preparation of medication for oral, parenteral use, combination, use of compounds, structural fragment, use of it, endothelin receptor antagonist, and, compound
DE59610175D1 (en) HYDANTO DERIVATIVES AS INTERMEDIATE PRODUCTS FOR PHARMACEUTICAL ACTIVE SUBSTANCES
PT101444A (en) SYNERGIZING ASSOCIATION WITH ANTAGONIST EFFECT OF RECEPTORS NK1 AND NK2, USE OF ANTAGONIST ACTIVITY OF NK1 AND NK2 RECEPTORS IN THEIR PREPARATION AND PHARMACEUTICAL COMPOSITION CONTAINING THE REFERENCE ASSOCIATION
IT1284766B1 (en) PIPERIDINE DERIVATIVES, PROCEDURE FOR THEIR OBTAINMENT AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
BR0211729A (en) Compounds, pharmaceutical compositions, process for manufacturing compounds, use of one or more compounds, and process for manufacturing pharmaceutical compositions
CO4940448A1 (en) GLASS MODIFICATION OF A MEDICINAL SUBSTANCE
IT1205665B (en) DERIVATIVES 1- (HYDROXYSTYRYL) -5H2,3-BENZODIAZEPINICS, PROCEDURE FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM
BR0107922A (en) Derivatives of dibenzo [b, f] azepine and their preparation

Legal Events

Date Code Title Description
FA10 Dismissal: dismissal - article 33 of industrial property law
B11Y Definitive dismissal - extension of time limit for request of examination expired [chapter 11.1.1 patent gazette]